Syed Rizvi, DPM
Foot & Ankle Surgery · Saint Louis, MONPI 1639752512
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (53.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Elite Orthopedics, LLC accounts for 61.1% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $2,881 and has fallen 61.3% since, to $1,113 in 2025.
Across 61 payments — averaging $147.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elite Orthopedics, LLC$6K
- Stryker$2K
- Treace Medical Concepts, Inc.$1K
- Arthrex$263
- Smith+Nephew$91
- Johnson & Johnson$71
- plus $92 from 4 others
What the payments were for
- Travel & lodging$2,38927%
- Food & beverage$1,81820%
- Education$4,80053%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elite Orthopedics, LLC | 17 | $5,504 |
| Stryker | 18 | $1,940 |
| Treace Medical Concepts, Inc. | 15 | $1,046 |
| Arthrex | 2 | $263 |
| Smith+Nephew | 4 | $91 |
| Johnson & Johnson | 1 | $71 |
| Medtronic | 1 | $38 |
| Linvatec Corporation | 1 | $25 |
| Solventum Corporation | 1 | $15 |
| Integra Lifesciences Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ORTHOLOC 2 LAPIFUSE$729
- ORTHOLOC 3DI$607
- LAPIPLASTY SYSTEM 1$389
- TMC NANOPLASTY SYSTEM$153
- ALLOGRAFT WEDGE SYSTEM$139
- AUGMENT INJECTABLE$115
How this compares
$9,007 in reported general payments places this provider in the 65th percentile of 163 foot & ankle surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole | 45 | $1,015 |
| CiclopiroxCiclopirox Olamine | 34 | $578 |
| Diclofenac Sodium | 15 | $253 |
| Cephalexin | 12 | $251 |
| Terbinafine Hcl | 15 | $162 |
| Methylprednisolone | 21 | $101 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Saint Louis
- Jeremy McCormickSaint Louis$1.5M
- Jeffrey JohnsonSaint Louis$944K
- Raymond AbdoSaint Louis$251K
- Vincent SollecitoSaint Louis$221K
- John HoltzmanSaint Louis$129K
- Jesse WolfeSaint Louis$89K
- Seth AndersonSaint Louis$45K
- Kelly HynesSaint Louis$34K
- Lindsay BarthSaint Louis$30K
- Andrew ThomeSaint Louis$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.